An Aging Healthy Intervention for Older Adults Delivered by Community Health Workers in Senior Centers: A Clinical Trial

by palligoelme@gmail.com | Aug 23, 2026 | Clinical Trials

​ Conditions: Healthy Aging Interventions: Behavioral: aCT CHW intervention Sponsors: George Mason University; University of Kentucky Not yet recruiting Conditions: Healthy Aging Interventions: Behavioral: aCT CHW intervention Sponsors: George Mason University;...

Physical Profile of Cervicogenic Headache: Comparison With Neck Pain and Healthy Controls

by palligoelme@gmail.com | Aug 21, 2026 | Clinical Trials

​ Conditions: Cervicogenic Headache; Chronic Neck Pain Sponsors: Istanbul Medipol University Hospital; Istanbul Kent University Recruiting Conditions: Cervicogenic Headache; Chronic Neck Pain Sponsors: Istanbul Medipol University Hospital; Istanbul Kent University...

Impact of Hypoalbuminemia on Cefoperazone/Sulbactam Induced Coagulopathy in Post-Operative Surgical Patients

by palligoelme@gmail.com | Aug 21, 2026 | Clinical Trials

​ Conditions: Hypoalbuminemia and Cefoperazone/Sulbactam Induced Coagulopathy Sponsors: Sheikh Zayed Federal Postgraduate Medical Institute Not yet recruiting Conditions: Hypoalbuminemia and Cefoperazone/Sulbactam Induced Coagulopathy Sponsors: Sheikh Zayed Federal...

Effect of a Telehealth Intervention on Depressive Symptoms Among Caregivers of Patients With Cerebral Palsy Receiving Home Care

by palligoelme@gmail.com | Aug 21, 2026 | Clinical Trials

​ Conditions: Depression Interventions: Behavioral: Behavioral Treatment Sponsors: Gülhane Research and Education Hospital Completed Conditions: Depression Interventions: Behavioral: Behavioral Treatment Sponsors: Gülhane Research and Education Hospital...

Study of d-MAPPS™ Ophthalmic Solution in Adults With Chronic Ocular Graft-Versus-Host Disease (oGVHD)

by palligoelme@gmail.com | Aug 21, 2026 | Clinical Trials

​ Conditions: oGVHD; Ocular Graft Versus Host Disease Interventions: Biological: d-MAPPS™ Ophthalmic Solution; Biological: Matching vehicle control Sponsors: Regenerative Ocular Immunobiologics LLC Not yet recruiting Conditions: oGVHD; Ocular Graft Versus Host Disease...

Venetoclax With Hypomethylating Agents in Newly Diagnosed AML Unfit for Intensive Chemotherapy

by palligoelme@gmail.com | Aug 21, 2026 | Clinical Trials

​ Conditions: Acute Myeloid Leukemia Interventions: Drug: Venetoclax; Drug: Azacitidine; Drug: Decitabine; Drug: Voriconazole Sponsors: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh Completed Conditions: Acute Myeloid Leukemia Interventions: Drug:...